Takahiro Muroya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Takahiro Muroya has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Chie Yasuoka
Department of Biochemistry and Molecular Biology in Disease, Atomic Bomb Disease Institute, Nagasaki University School of Medicine, Nagasaki 852-8523, Japan
2 shared publications- Satoshi Ikeda
Stroke and Cardiovascular Diseases Support Center, Nagasaki University Hospital
2 shared publications Shigeru Kohno
Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki 852-8521, Japan
2 shared publicationsTakahito Kondo
Department of Biochemistry and Molecular Biology in Disease, Atomic Bomb Disease Institute, Nagasaki University School of Medicine, Nagasaki 852-8523, Japan
2 shared publicationsYoshishige Urata
Department of Biochemistry and Molecular Biology in Disease, Atomic Bomb Disease Institute, Nagasaki University School of Medicine, Nagasaki 852-8523, Japan
2 shared publicationsYoshiyuki Miyahara
Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki 852-8521, Japan
2 shared publications
Latest Publications
- Open Access
- 6 February 2024
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 67 (5) , 1199-1210
Association between left atrial low-voltage area and induction and recurrence of macroreentrant atrial tachycardia in pulmonary vein isolation for atrial fibrillation
Background: The relationship between induction and recurrence due to atrial tachycardia (AT) and left atrial (LA) matrix progression after atrial fibrillation (AF) ablation remains unclear. Methods: One hundred fifty-two consecutive patients with paroxysmal and persistent AF who underwent pulmonary vein isolation (PVI) and cavo-tricuspid isthmus (CTI) ablation and achieved sinus rhythm before the procedure were classified into three groups according to the AT pattern induced after the procedure: group N (non-induced), F (focal pattern), and M (macroreentrant pattern) in 3D mapping. Results: The total rate of AT induction was 19.7% (30/152) in groups F (n = 13) and M (n = 17). Patients in group M were older than those in groups N and F, with higher CHADS2/CHA2DS2-VASc values, left atrial enlargement, and low-voltage area (LVA) size of LA. The receiver operating characteristic curve determined that the cut-off LVA for macroreentrant AT induction was 8.8 cm2 (area under the curve [AUC]: 0.86, 95% confidence interval [CI]: 0.75–0.97). The recurrence of AT at 36 months in group N was 4.1% (5/122), and at the second ablation, all patients had macroreentrant AT. Patients with AT recurrence in group N had a wide LVA at the first ablation, and the cut-off LVA for AT recurrence was 6.5 cm2 (AUC 0.94, 95%CI 0.88–0.99). Adjusted multivariate analysis showed that only LVA size was associated with the recurrence of macroreentrant AT (odds ratio 1.21, 95%CI 1.04–1.51). Conclusions: It is important to develop a therapeutic strategy based on the LVA size to suppress the recurrence of AT in these patients. Graphical
- 6 February 2024
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 67 (5) , 1199-1210
Open AccessAssociation between left atrial low-voltage area and induction and recurrence of macroreentrant atrial tachycardia in pulmonary vein isolation for atrial fibrillation
Background: The relationship between induction and recurrence due to atrial tachycardia (AT) and left atrial (LA) matrix progression after atrial fibrillation (AF) ablation remains unclear. Methods: One hundred fifty-two consecutive patients with paroxysmal and persistent AF who underwent pulmonary vein isolation (PVI) and cavo-tricuspid isthmus (CTI) ablation and achieved sinus rhythm before the procedure were classified into three groups according to the AT pattern induced after the procedure: group N (non-induced), F (focal pattern), and M (macroreentrant pattern) in 3D mapping. Results: The total rate of AT induction was 19.7% (30/152) in groups F (n = 13) and M (n = 17). Patients in group M were older than those in groups N and F, with higher CHADS2/CHA2DS2-VASc values, left atrial enlargement, and low-voltage area (LVA) size of LA. The receiver operating characteristic curve determined that the cut-off LVA for macroreentrant AT induction was 8.8 cm2 (area under the curve [AUC]: 0.86, 95% confidence interval [CI]: 0.75–0.97). The recurrence of AT at 36 months in group N was 4.1% (5/122), and at the second ablation, all patients had macroreentrant AT. Patients with AT recurrence in group N had a wide LVA at the first ablation, and the cut-off LVA for AT recurrence was 6.5 cm2 (AUC 0.94, 95%CI 0.88–0.99). Adjusted multivariate analysis showed that only LVA size was associated with the recurrence of macroreentrant AT (odds ratio 1.21, 95%CI 1.04–1.51). Conclusions: It is important to develop a therapeutic strategy based on the LVA size to suppress the recurrence of AT in these patients. Graphical
- Open Access
- 12 December 2023
- Published by Wiley in Health Science Reports
- Vol. 6 (12) , e1714
Coronary microvascular resistance comparison of coronary arteries with and without considering vascular diameter: A retrospective, single‐center study
Background and Aims: Measurement of coronary microvascular resistance (MR) is essential for diagnosing nonocclusive coronary artery ischemia, but whether coronary branches of different diameters can be similarly assessed using hyperemic microvascular resistance index (hMVRI) calculated from average peak velocity (APV) remains unclear. We investigated the relationship between coronary arteries of different diameters and hMVRI.Methods: Thirty patients with suspected angina pectoris and nonobstructive coronary stenosis with fractional flow reserve >0.8 underwent evaluation of all coronary arteries using a Doppler velocity and pressure‐equipped guidewire. Quantitative coronary angiography (QCA) was used to analyze vessel diameter (DQCA). Coronary blood flow (CBFQCA) was calculated as πDQCA2/4 (0.5 × APV) and hMVRIQCA as distal coronary pressure divided by CBFQCA during maximal hyperemia.Results: The hMVRI was significantly higher for the right coronary artery than for the left anterior descending artery, but no significant differences between arteries were seen for CBFQCA and hMVRIQCA. Although the correlation between CBFQCA and APV was weak, CBFQCA divided into three groups according to DQCA showed very strong correlations with APV. Slopes of the straight line between APV and CBFQCA for small‐, middle‐, and large‐diameter groups were 0.48, 0.30, and 0.21, respectively, with slope decreasing as diameter increased.Conclusions: Comparative evaluation of MR in coronary branches with varying vessel diameters requires vessel diameter to be accounted for.
- 12 December 2023
- Published by Wiley in Health Science Reports
- Vol. 6 (12) , e1714
Open AccessCoronary microvascular resistance comparison of coronary arteries with and without considering vascular diameter: A retrospective, single‐center study
Background and Aims: Measurement of coronary microvascular resistance (MR) is essential for diagnosing nonocclusive coronary artery ischemia, but whether coronary branches of different diameters can be similarly assessed using hyperemic microvascular resistance index (hMVRI) calculated from average peak velocity (APV) remains unclear. We investigated the relationship between coronary arteries of different diameters and hMVRI.Methods: Thirty patients with suspected angina pectoris and nonobstructive coronary stenosis with fractional flow reserve >0.8 underwent evaluation of all coronary arteries using a Doppler velocity and pressure‐equipped guidewire. Quantitative coronary angiography (QCA) was used to analyze vessel diameter (DQCA). Coronary blood flow (CBFQCA) was calculated as πDQCA2/4 (0.5 × APV) and hMVRIQCA as distal coronary pressure divided by CBFQCA during maximal hyperemia.Results: The hMVRI was significantly higher for the right coronary artery than for the left anterior descending artery, but no significant differences between arteries were seen for CBFQCA and hMVRIQCA. Although the correlation between CBFQCA and APV was weak, CBFQCA divided into three groups according to DQCA showed very strong correlations with APV. Slopes of the straight line between APV and CBFQCA for small‐, middle‐, and large‐diameter groups were 0.48, 0.30, and 0.21, respectively, with slope decreasing as diameter increased.Conclusions: Comparative evaluation of MR in coronary branches with varying vessel diameters requires vessel diameter to be accounted for.
- Open Access
- 1 June 2014
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 31, 208
Oxygen mask capnometry typeR is useful device for continuous CO2 monitoring during different breathing patterns in extubated post abdominal surgical patients: a prospective observational study
- 1 June 2014
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 31, 208
Open AccessOxygen mask capnometry typeR is useful device for continuous CO2 monitoring during different breathing patterns in extubated post abdominal surgical patients: a prospective observational study
- 1 October 2003
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 309 (4) , 900-905
Oxidative modulation of NF-κB signaling by oxidized low-density lipoprotein
- 1 October 2003
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 309 (4) , 900-905
Oxidative modulation of NF-κB signaling by oxidized low-density lipoprotein
- 1 August 2002
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 296 (1) , 32-40
N-(Carboxymethyl)lysine induces γ-glutamylcysteine synthetase in RAW264.7 cells
- 1 August 2002
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 296 (1) , 32-40
N-(Carboxymethyl)lysine induces γ-glutamylcysteine synthetase in RAW264.7 cells